| Size | Price | Stock |
|---|---|---|
| 100 mg | Get quote | |
| 250 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-101537 |
| M.Wt: | 479.67 |
| Formula: | C31H37N5 |
| Purity: | >98 % |
| Solubility: |
GPR4 antagonist 2 is a selective GPR4 antagonist with an IC50 of 67 nM. GPR4 antagonist 2 inhibits pH-dependent GPR4 activation and CRE-driven transcriptional activity. GPR4 antagonist 2 prolongs the survival of mice in a myocardial infarction model. GPR4 antagonist 2 can be used for research on myocardial infarction[1].
In Vitro:GPR4 antagonist 2 (compound 3b) (10 μM) is a potent antagonist of pH-dependent GPR4 activation in HEK293 cells expressing GPR4, with a CRE activity ratio of 0.39 and an IC50 of 67 nM[1].
GPR4 antagonist 2 (10 μM) shows no activity against TDAG8 or OGR1 in HEK293 cells expressing these receptors[1].
In Vivo:GPR4 antagonist 2 (compound 3b) (6.7 mg/kg/day; i.p.; twice daily) achieves a 100% mouse survival rate in a mouse myocardial infarction model[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.